Haha! According to Bpharma he though Indonesia was paying for the trial!
But yeah, they might struggle to fill this entitlement. Some cheeky options may have helped.
And I struggle to see how they commercialise in 2026 when AFAIK they haven't even started the Indo trial? It was supposed to start in Dec 2024... so already 4 months late?
Ann: Placement and Entitlement Offer to Fund Phase III Trials, page-9
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
32.5¢ |
Change
0.020(6.56%) |
Mkt cap ! $89.39M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 33.0¢ | 30.0¢ | $75.15K | 239.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10934 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 14999 | 1 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |